These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16606962)

  • 21. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
    Khan SP; Ghani R; Ahmed KZ; Yaqoob Z
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels.
    Funabashi S; Kataoka Y; Hori M; Ogura M; Doi T; Noguchi T; Harada-Shiba M
    J Am Heart Assoc; 2022 Aug; 11(16):e025232. PubMed ID: 35929461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia.
    Hegele RA
    Genome; 2006 Nov; 49(11):1343-50. PubMed ID: 17426749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.
    Vuorio A; Watts GF; Schneider WJ; Tsimikas S; Kovanen PT
    J Intern Med; 2020 Jan; 287(1):2-18. PubMed ID: 31858669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and genetic differences between heterozygous familial hypercholesterolemia patients with and without type 2 diabetes.
    Climent E; Pérez-Calahorra S; Benaiges D; Pintó X; Suárez-Tembra M; Plana N; Sánchez-Hernández RM; Valdivielso P; Ascaso JF; Pedro-Botet J
    Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):718-724. PubMed ID: 31672559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study.
    Kjærgaard KA; Harborg S; Jensen HK; Borgquist S
    Lipids Health Dis; 2022 Jul; 21(1):56. PubMed ID: 35780163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases.
    Hu M; Lan W; Lam CW; Mak YT; Pang CP; Tomlinson B
    Int J Cardiol; 2013 Aug; 167(3):762-7. PubMed ID: 22464486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender.
    Mattina A; Giammanco A; Giral P; Rosenbaum D; Carrié A; Cluzel P; Redheuil A; Bittar R; Béliard S; Noto D; Quartarone A; Averna M; Bruckert É; Gallo A
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1068-1076. PubMed ID: 31378630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygous familial hypercholesterolemia presenting as chylomicronemia syndrome.
    Rosenson RS; Najera SD; Hegele RA
    J Clin Lipidol; 2017; 11(1):294-296. PubMed ID: 28391899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.
    Pijlman AH; Huijgen R; Verhagen SN; Imholz BP; Liem AH; Kastelein JJ; Abbink EJ; Stalenhoef AF; Visseren FL
    Atherosclerosis; 2010 Mar; 209(1):189-94. PubMed ID: 19818960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
    Gallo A; Charriere S; Vimont A; Chapman MJ; Angoulvant D; Boccara F; Cariou B; Carreau V; Carrié A; Bruckert E; Béliard S;
    Atherosclerosis; 2020 Aug; 306():41-49. PubMed ID: 32688103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry.
    Béliard S; Boccara F; Cariou B; Carrié A; Collet X; Farnier M; Ferrières J; Krempf M; Peretti N; Rabès JP; Varret M; Vimont A; Charrière S; Bruckert E;
    Atherosclerosis; 2018 Oct; 277():334-340. PubMed ID: 30270068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
    Aljenedil S; Ruel I; Watters K; Genest J
    J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis.
    Huijgen R; Stork AD; Defesche JC; Peter J; Alonso R; Cuevas A; Kastelein JJ; Duran M; Stroes ES
    Clin Genet; 2012 Jan; 81(1):24-8. PubMed ID: 21955034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.
    Descamps OS; Tenoutasse S; Stephenne X; Gies I; Beauloye V; Lebrethon MC; De Beaufort C; De Waele K; Scheen A; Rietzschel E; Mangano A; Panier JP; Ducobu J; Langlois M; Balligand JL; Legat P; Blaton V; Muls E; Van Gaal L; Sokal E; Rooman R; Carpentier Y; De Backer G; Heller FR
    Atherosclerosis; 2011 Oct; 218(2):272-80. PubMed ID: 21762914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.
    Foody JM; Vishwanath R
    J Clin Lipidol; 2016; 10(4):970-986. PubMed ID: 27578130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.